India's Cadila Healthcare starts producing COVID-19 vaccine candidate

By Sumit Khanna

AHMEDABAD, India, April 23 (Reuters) - India's Cadila Healthcare CADI.NS has started producing its potential COVID-19 vaccine for which it will seek emergency use authorisation in May or June, its managing director told Reuters, with an aim to make up to 240 million doses a year.

"We have just started producing doses," Sharvil Patel said in a Microsoft Teams interview on Friday. "But it is not meaningfully large."

(Writing by Krishna N. Das; Editing by Catherine Evans)

((; +91 987111 8314;))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


More Related Articles

Info icon

This data feed is not available at this time.

Sign up for Smart Investing to get the latest news, strategies and tips to help you invest smarter.